Dimensional Fund Advisors
CAPR icon

Dimensional Fund Advisors’s Capricor Therapeutics CAPR Stock Holding History

Dimensional Fund Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,839
Closed -$72.6K – 3396
2023
Q4 		$72.6K Sell
14,839
-9,246
-38% -$30.1K ﹤0.01% 3309
2023
Q3 		$82.4K Hold
24,085
– – ﹤0.01% 3337
2023
Q2 		$115K Sell
24,085
-74,112
-75% -$326K ﹤0.01% 3304
2023
Q1 		$414K Sell
98,197
-64,923
-40% -$280K ﹤0.01% 3068
2022
Q4 		$629 Hold
163,120
– – ﹤0.01% 2998
2022
Q3 		$978K Buy
163,120
+9,706
+6% +$49.6K ﹤0.01% 2885
2022
Q2 		$535K Buy
153,414
+4,646
+3% +$16.5K ﹤0.01% 3049
2022
Q1 		$510K Buy
148,768
+52,611
+55% +$208K ﹤0.01% 3146
2021
Q4 		$282K Buy
96,157
+67,536
+236% +$237K ﹤0.01% 3283
2021
Q3 		$115K Buy
+28,621
New +$130K ﹤0.01% 3415

Other funds holding CAPR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors's CAPR Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Capricor Therapeutics (CAPR) in Q1 2024, closing a stake of 14,839 shares — an estimated $72.6K sold.

Dimensional Fund Advisors first reported a position in CAPR in Q3 2021 and held it in 10 quarters. The position peaked at $978K in Q3 2022. 56 funds tracked by Wall St. Rank hold CAPR as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Capricor Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,839 Capricor Therapeutics shares in Q1 2024, an estimated $72.6K.
  • Dimensional Fund Advisors first reported a position in Capricor Therapeutics in Q3 2021 and held it in 10 quarters.
  • Dimensional Fund Advisors's Capricor Therapeutics position peaked at $978K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.